The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants
Abstract
BACKGROUND: Chronic lung disease (CLD) remains a major problem in neonatal intensive care units. Persistent inflammation in the lungs is the most likely underlying pathogenesis. Corticosteroids have been used to either prevent or treat CLD because of their potent anti-inflammatory effects. OBJECTIVES: To determine if postnatal corticosteroid treatment is of benefit in the prevention of chronic lung disease (CLD) in the preterm infant. This review examines the outcome of trials where preterm infants at risk of CLD were given postnatal steroids within 96 hours after birth. SEARCH STRATEGY: Randomised controlled trials of postnatal corticosteroid therapy were sought from the Oxford Database of Perinatal Trials, the Cochrane Controlled Trials Register, Medline, hand searching paediatric and perinatal journals, examining previous review articles and information received from practising neonatologists. SELECTION CRITERIA: Randomised controlled trials of postnatal corticosteroid treatment within 96 hours of birth (early) in high risk preterm infants were selected for this review. DATA COLLECTION AND ANALYSIS: Data regarding clinical outcomes including mortality, failure to extubate, pulmonary air leak, survival without chronic lung disease, CLD defined at 28 days postnatal age and 36 weeks post menstrual age, patent ductus arteriosus (PDA), severe intraventricular haemorrhage (IVH), periventricular leucomalacia (PVL), infection, hyperglycaemia, hypertension, severe retinopathy of prematurity (ROP), necrotising enterocolitis (NEC), gastrointestinal bleeding, intestinal perforation and long-term outcomes were abstracted and analysed using RevMan 4.1. MAIN RESULTS: Nineteen randomised controlled trials of early postnatal corticosteroid treatment of preterm babies at risk of developing CLD were identified. A meta-analysis of these trials demonstrates benefits as regards earlier extubation, decreased risks of CLD at both 28 days and 36 weeks, death or CLD at 28 days, PDA and pulmonary air leak. There were no differences in the rates of neonatal mortality, infection, severe ROP, severe IVH, PVL, NEC and pulmonary haemorrhage. Gastrointestinal bleeding and intestinal perforation were important adverse effects and the risks of hyperglycaemia and hypertension were also increased. In the two trials which have reported late outcomes, several adverse neurological effects were found at follow-up examinations of survivors treated with early steroids: abnormal neurological examination, cerebral palsy and developmental delay. REVIEWER'S CONCLUSIONS: The benefits of early postnatal corticosteroid treatment (< 96 hours) may not outweigh the known or potential adverse effects of this treatment. Adverse gastrointestinal effects early in the neonatal period and adverse neurological outcomes seen at follow-up mean that current use of early postnatal steroids needs to be reconsidered. There is a compelling need for the long term follow-up and reporting of late outcomes, especially neurological and developmental outcomes, among surviving infants who participated in all randomised trials of early postnatal corticosteroid treatment. The role of inhaled steroids remains to be elucidated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Johnson, A. P. (2024) · Being and Becoming Teachers of Writing · doi:10.4324/9781003334798-34 · Cited by 4,502
Adverse Effects of Early Dexamethasone Treatment in Extremely-Low-Birth-Weight Infants
Stark, A. R., Carlo, W. A., Tyson, J. E., Papile, L.-A., Wright, L. L., Shankaran, S., Donovan, E. F., Oh, W., Bauer, C. R., Saha, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101113440203 · Cited by 479
Self-citationEarly Dexamethasone Therapy in Preterm Infants: A Follow-up Study
Yeh, T. F., Lin, Y. J., Huang, C. C., Chen, Y. J., Lin, C. H., Lin, H. C., Hsieh, W. S., & Lien, Y. J. (1998) · Pediatrics · doi:10.1542/peds.101.5.e7 · Cited by 418
Antenatal Glucocorticoid Treatment and Cystic Periventricular Leukomalacia in Very Premature Infants
Baud, O., Foix-L'Helias, L., Kaminski, M., Audibert, F., Jarreau, P.-H., Papiernik, E., Huon, C., Lepercq, J., Dehan, M., & Lacaze-Masmonteil, T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411604 · Cited by 414
Early postnatal dexamethasone treatment and increased incidence of cerebral palsy
Shinwell, E. S., Karplus, M., Reich, D., Weintraub, Z., Blazer, S., Bader, D., Yurman, S., Dolfin, T., Kogan, A., Dollberg, S., et al. (2000) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/fn.83.3.f177 · Cited by 368
CONTROLLED TRIAL OF DEXAMETHASONE THERAPY IN INFANTS WITH BRONCHOPULMONARY DYSPLASIA
Mammel, M., Johnson, D., Green, T., & Thompson, T. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92139-6 · Cited by 307
Prophylaxis Against Early Adrenal Insufficiency to Prevent Chronic Lung Disease in Premature Infants
Watterberg, K. L., Gerdes, J. S., Gifford, K. L., & Lin, H.-M. (1999) · Pediatrics · doi:10.1542/peds.104.6.1258 · Cited by 256
Evidence of Early Adrenal Insufficiency in Babies Who Develop Bronchopulmonary Dysplasia
Watterberg, K. L., & Scott, S. M. (1995) · Pediatrics · doi:10.1542/peds.95.1.120 · Cited by 237
Halac, E., Halac, J., Bégué, E. F., Casañas, J. M., Indiveri, D. R., Petit, J. F., Figueroa, M. J., Olmas, J. M., Rodriíguez, L. A., Obregón, R. J., et al. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)72461-6 · Cited by 191
Yeh, T. F., Lin, Y. J., Hsieh, W. S., Lin, H. C., Lin, C. H., Chen, J. Y., Kao, H. A., & Chien, C. H. (1997) · Pediatrics · doi:10.1542/peds.100.4.e3 · Cited by 184
Cited by
Ehrenkranz, R. A., Dusick, A. M., Vohr, B. R., Wright, L. L., Wrage, L. A., Poole, W. K., & for the National Institutes of Child Health and Human Development Neonatal Research Network (2006) · Pediatrics · doi:10.1542/peds.2005-1368 · Cited by 1,356
Self-citationValidation of the National Institutes of Health Consensus Definition of Bronchopulmonary Dysplasia
Ehrenkranz, R. A., Walsh, M. C., Vohr, B. R., Jobe, A. H., Wright, L. L., Fanaroff, A. A., Wrage, L. A., Poole, K., & for the National Institutes of Child Health and Human Development Neonatal Research Network (2005) · Pediatrics · doi:10.1542/peds.2005-0249 · Cited by 1,146
Self-citationTrends in Mortality and Morbidity for Very Low Birth Weight Infants, 1991–1999
Horbar, J. D., Badger, G. J., Carpenter, J. H., Fanaroff, A. A., Kilpatrick, S., LaCorte, M., Phibbs, R., Soll, R. F., & for the Members of the Vermont Oxford Network (2002) · Pediatrics · doi:10.1542/peds.110.1.143 · Cited by 772
Dalziel, S. R., Walker, N. K., Parag, V., Mantell, C., Rea, H. H., Rodgers, A., & Harding, J. E. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66617-2 · Cited by 461
Wood, N. S., Costeloe, K., Gibson, A. T., Hennessy, E. M., Marlow, N., & Wilkinson, A. R. (2005) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/adc.2004.052407 · Cited by 424
Metadata
- Authors
- Halliday, H., Ehrenkranz, R., & Doyle, L.
- Venue
- The Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2003-01-20
- Issue
- 1
- Pages
- CD001146-CD001146
- OpenAlex
- W1915832533
- Cited by
- 303
- References
- 26
- Type
- reference entry
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. https://app.cochat.ai/papers/10.1002/14651858.cd001146
- The paper
- Halliday, H., Ehrenkranz, R., & Doyle, L. (2003). Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. The Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd001146
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.